Status | Study |
Completed |
Study Name: Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection Condition: Cytomegalovirus Disease Date: 2012-01-10 Interventions: Drug: Valganciclovir Valcyte p |
Completed |
Study Name: Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection Condition: Cytomegalovirus Infection Date: 2009-04-14 Interventions: Drug: HCMV-specific hyperimmune globulin (Cytotect®) |
Completed |
Study Name: Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients Condition: Cytomegalovirus Infection Date: 2008-10-15 |
Completed |
Study Name: Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients Condition: Cytomegalovirus Infection Date: 2008-08-05 Interventions: Drug: Single arm (ganciclovir and valganciclovir) Patients received a short induction of IV ganciclovir |
Completed |
Study Name: Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients Condition: Cytomegalovirus Infection Date: 2008-06-13 Interventions: Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings |
Completed |
Study Name: Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients Condition: Cytomegalovirus Infections Date: 2007-07-05 Interventions: Drug: maribavir 100mg twice a |
Completed |
Study Name: Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections Condition: Cytomegalovirus Infection Date: 2007-04-26 Interventions: Other: Placebo 9 grams of powd |
Completed |
Study Name: Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients Condition: Cytomegalovirus Infections Date: 2006-12-12 Interventions: Drug: maribavir 100 mg twice d |
Completed |
Study Name: Study of Prophylactic Vs Preemptive Valganciclovir Condition: Cytomegalovirus Infection Date: 2006-09-07 Interventions: Drug: Valganciclovir |
Completed |
Study Name: IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients Condition: Cytomegalovirus Infections Date: 2006-02-21 Interventions: Drug: Valganciclovir 900 mg or |